Company intelligence / Profile preview

Unda

Harzé, Liège, Belgium

Ownership: Private
Development stage: Other

Overview

Unda is a Belgian pharmaceutical company specializing in the manufacture of homeopathic remedies and herbal supplements. Founded in 1949, the company is best known for its Unda Numbered Compounds, which are complex homeopathic preparations designed to support organ function and systemic detoxification. Unda also produces gemmotherapy macerates, oligotherapy elements, and other natural health products. The company operates as a subsidiary of Atrium Innovations, which was acquired by Nestlé Health Science in 2017. Its products are widely used by integrative and naturopathic practitioners globally for chronic and acute conditions.

Therapeutic areas: ImmunologyOtherRheumatologyPulmonologyGastroenterology
Modalities: Homeopathic remedyPlant extractMineral supplement
Industry: Food & Nutrition

Partnerships

Seroyal

Beyond the preview

Go deeper on Unda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unda.

Explore the full profile